text.skipToContent text.skipToNavigation
+49 (0)281 9887 0

LGC Standards offers reference materials for 31 legal highs banned by new 2010 Europol Report

Date:13 May 2011

Since April 2010, LGC Standards, Europe?s leading supplier of reference materials, has been characterising and developing reference materials to assist forensic, clinical and toxicology laboratories to identify and quantify ?legal high? drugs or ?research Chemicals? such as mephedrone, methiopropamine, MDAI and methoxetamine.

The European Monitoring Centre for Drug and Drug Addiction (EMCDDA) - Europol 2010 Annual Report on New Drugs*, lists 41 psychoactive substances that had been officially reported to either organisation for the first time in 2010. The substances reported include novel cathinones, synthetic cannabinoids and stimulants which are commonly termed ?legal highs? or ?research chemicals?. While many of these substances were completely new chemical compounds, a number of the reported substances had previously been reported in scientific literature as potential therapeutic agents.

The ?legal highs? reference material programme?s specific aims were to produce and source high quality ?legal high? or ?research chemical? reference materials with many of the novel compounds being produced at LGC Standards? facility in Luckenwalde, Germany. To date, the programme has sourced or produced over 330 primary drug reference standards, including 31 of the materials listed in the EMCDDA-Europol report.

Dr Peter Pack, Managing Director of LGC Standards said: ?LGC Standards? production and supply strategy is such that we have been able to bring to market many of these products far more rapidly than traditional reference material production would permit, whilst maintaining the quality of the final product. We are already anticipating what new legal highs may appear in 2011 and beyond and have produced a number of products in advance to allow laboratories to meet these new analytical challenges.?

For further information on legal high reference standards and other available products, please contact LGC Standards by email: askus@lgcstandards.com or tel: +44 (0)20 8943 8480.

Further information on legal highs can be found at: http://www.talktofrank.com/drugs.aspx?id=3597

- Ends -

Notes to editors
About LGC Standards
LGC Standards (www.lgcstandards.com) provides products and services to improve measurement and quality control within the laboratory, and is part of LGC, whose LGC Science & Technology Division acts as the UK National Measurement Institute for chemical and bioanalytical measurements. LGC Standards supplies over 100,000 products, including reference materials, pharmaceutical impurity reference standards (produced under ISO Guide 34 accreditation), biological standards and reagents, and proficiency testing. LGC Standards is headquartered in Teddington, Middlesex, UK. Its global centre for excellence in proficiency testing is located in Bury (Greater Manchester). LGC Standards has offices in France, Germany, Italy, Poland, Spain, Sweden, China, Russia, United Arab Emirates and the UK, a joint venture presence in India, and representatives in Brazil, Bulgaria, Czech Republic, Finland, Hungary, Ireland, the Netherlands, Romania, Turkey and the US.

About LGC
LGC (www.lgcgroup.com) is an international science-based company and market leader in analytical, forensic and diagnostic services and reference standards. LGC operates in a variety of markets which underpin the safety, health and security of the public and the regulation of industry, for both public and private sector clients.

LGC operates internationally through four divisions - LGC Forensics, LGC Genomics, LGC Standards and LGC Science & Technology. The latter includes specialist laboratories delivering contracts for the Department for Business, Innovation and Skills (BIS) and supports LGC's designated role as the UK's National Measurement Institute for chemical and bioanalytical measurement.

Our operations are extensively accredited to international quality standards such as ISO 17025. With headquarters in Teddington, South West London, the LGC Group employs ca 1,400 staff in 29 laboratories and centres globally. Privatised in 1996 and now majority-owned by funds managed by Bridgepoint, LGC was founded almost 170 years ago as the Laboratory of the Government Chemist - a statutory function maintained by LGC today.

* The European Monitoring Centre for Drug and Drug Addiction (EMCDDA) - Europol 2010 Annual Report on New Drugs was published on 11 May 2001. Visit: http://www.emcdda.europa.eu/ or http://www.europol.europa.eu/

For further information contact:
Amanda Russell
Marketing Manager
LGC Standards
Queens Road
TW11 0LY
Tel: +44 (0)20 8943 7412
Fax: +44 (0)20 8943 7009
Email: amanda.russell@lgcstandards.com

Gavin Dallas
Press & Communications Officer
Queens Road
TW11 0LY
Tel: +44 (0)20 8943 8491
Fax: +44 (0)20 8943 2767
Email: gavin.dallas@lgcgroup.com



Refine your


Online Ordering made easy


Sign up to our email newsletter



Punchout session timeout warning

Your punchout session will expire in 1 min 59 sec.

Select "Continue session" to extend your session.